US biotech major Gilead Sciences was trading nearly 5% higher in Wednesday’s pre-market trading after presenting its fourth ...

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...

The partnership will integrate PhaseV's adaptive clinical trial technology with Alimentiv's comprehensive GI CRO services.

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

The latest ASX small and microcap health news covering everything from drug and biotech developments to medical devices and medicinal cannabis.

Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) had its price objective decreased by JMP Securities from $23.00 to $14.00 in a research note issued to investors on Thursday morning,Benzinga ...

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) shares reached a new 52-week low during trading on Friday after JMP Securities lowered their price target on the stock from $23.00 to $14 ...

AbbVie (ABBV) stock was one of the top gainers in the S&P 500 Friday morning as the biotech firm posted better-than-expected sales and gave strong guidance on higher demand for two of its drugs to ...

Let's take a look at the biotech stocks awaiting FDA decisions in February. Supernus Pharmaceuticals Inc. (SUPN) The FDA decision on Supernus Pharma's SPN-830, an investigational apomorphine ...

(RTTNews) - February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart Month was officially declared by President Lyndon B.